Recent Updates
Recently added Catalysts
LLY Positive Sentiment

Lilly to participate in Morgan Stanley 22nd Annual Global Healthcare Conference Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024. Jacob Van Naarden,...

Thursday, August 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Eli Lilly and Company (NYSE: LLY) is set to participate in the Morgan Stanley 22nd Annual Global Healthcare Conference scheduled for September 5, 2024. Jacob Van Naarden, the executive vice president and president of Lilly Oncology, will engage in a fireside chat during the event. Attendees can access a live audio webcast of the session through Lilly's Investor website, and a replay will be accessible for approximately 90 days following the event.
Price reaction · baseline $951.97 (2024-08-21 close) · hit after-hours · 1 other LLY headline(s) in the window, move may be shared
day 0 close · peak
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a major global healthcare conference highlights industry recognition.
  • Opportunity for increased visibility and engagement with investors.
  • Featuring a high-level executive indicates confidence in company strategies.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

INDIANAPOLIS , Aug. 22, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024 . Jacob Van Naarden , executive vice president and president, Lilly Oncology, will participate in a fireside chat at 7:45 a.m. Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.

Frequently Asked Questions

When is Eli Lilly's presentation at the Morgan Stanley Conference?

Eli Lilly will present on September 5, 2024.

Who will represent Eli Lilly at the conference?

Jacob Van Naarden, Lilly Oncology president, will represent Eli Lilly.

How can I access the live audio webcast?

The webcast is available on Lilly's Investor website under 'Webcasts & Presentations.'

Will there be a replay of the presentation?

Yes, a replay will be accessible for about 90 days on the same website.

Who can I contact for media inquiries?

Contact Jordan Bishop at 317-473-5712 for media inquiries.

ShareAdd on Google
Tags: LLY Viatris Investor Conferences Healthcare Eli Lilly Morgan Stanley healthcare conference investment
Last updated: Aug 22, 2024

Biotech snapshot

Cash runway
$8950M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DulaglutidePhase 3
Type 2 Diabetes Mellitus →

Catalyst track record

+45%
best trade around LLY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for LLY.

See every catalyst's timing & PoA →